Storia in 5 fonti

GSK prepares for patent cliff with $2.5B cost-cutting plan

The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.

Raccontata da

Confronto fonti

5 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo1 g fa

GSK prepares for patent cliff with $2.5B cost-cutting plan

The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.

originale

Timeline cronologica

martedì 28 luglio 2026·biopharmadive.com
GSK prepares for patent cliff with $2.5B cost-cutting plan
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
martedì 28 luglio 2026·cityam.com
Sweeping job cuts at GSK to fund £400m Cambridge campus
GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge in a move aimed a bolstering its pipeline.

GSK prepares for patent cliff with $2.5B cost-cutting plan

Confronto fonti

GSK prepares for patent cliff with $2.5B cost-cutting plan

Timeline cronologica

GSK prepares for patent cliff with $2.5B cost-cutting plan

Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

GSK lays out plans to cut costs, pursue more late-stage drug trials

Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain

GSK lays out plans to cut costs, pursue more late-stage drug trials